Index
S&P 500
Market Cap
57.94B
Enterprise Value
54.09B
Income
-3.15B
Sales
2.23B
Book/sh
16.94
Cash/sh
12.87
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
4700
IPO
Dec 07, 2018
P/E
-
Forward P/E
-
PEG
-
P/S
26.01
P/B
8.56
P/C
11.28
P/FCF
-
EV/EBITDA
-
EV/Sales
24.28
Quick Ratio
2.18
Current Ratio
2.29
Debt/Eq
0.19
LT Debt/Eq
0.18
Option/Short
Yes / Yes
EPS (ttm)
-7.98
EPS next Y
-4.88
EPS next Q
-1.16
EPS this Y
-17.04%
EPS next Y
42.58%
EPS next 5Y
27.68%
EPS past 3/5Y
- -29.93%
Sales past 3/5Y
-53.32% 19.33%
EPS Y/Y TTM
-6.22%
Sales Y/Y TTM
-27.62%
EPS Q/Q
7.60%
Sales Q/Q
2.11%
Insider Own
8.51%
Insider Trans
-2.45%
Inst Own
79.88%
Inst Trans
2.13%
ROA
-27.43%
ROE
-39.00%
ROIC
-39.41%
Gross Margin
12.57%
Oper. Margin
-149.01%
Profit Margin
-141.43%
SMA20
99.99%
SMA50
114.68%
SMA200
197.84%
Trades
Shs Outstand
399.00M
Shs Float
365.28M
52W High
176.66 -17.85%
52W Low
22.28 551.39%
Volatility
20.64% 9.79%
ATR (14)
14.89
RSI (14)
71.60
Beta
1.02
Rel Volume
7.63
Avg Volume
11.44M
Volume
87,316,065
Perf Week
129.20%
Perf Month
154.52%
Perf Quarter
207.09%
Perf Half Y
191.02%
Perf YTD
392.13%
Perf Year
453.51%
Perf 3Y
30.65%
Perf 5Y
-62.11%
Perf 10Y
-
Prev Close
133.32
Price
145.13
Change %
8.86%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-19-26 Upgrade
William Blair
Mkt Perform → Outperform
Aug-19-26 Upgrade
BofA Securities
Underperform → Neutral
Jan-28-26 Resumed
Barclays
Equal Weight
$25
Jan-07-26 Resumed
UBS
Neutral
$34
Dec-12-25 Initiated
Jefferies
Hold
$30
Mar-13-25 Initiated
Citigroup
Neutral
$40
Feb-18-25 Downgrade
Barclays
Overweight → Equal Weight
$111 → $45
Jan-29-25 Downgrade
Goldman
Buy → Neutral
$99 → $51
Dec-18-24 Downgrade
Argus
Buy → Hold
Dec-10-24 Resumed
BofA Securities
Underperform
$41
Nov-19-24 Initiated
Berenberg
Hold
$42
Nov-18-24 Upgrade
HSBC Securities
Hold → Buy
$58
Nov-15-24 Initiated
Wolfe Research
Underperform
$40
Oct-17-24 Initiated
Bernstein
Mkt Perform
$55
Sep-13-24 Downgrade
Oppenheimer
Outperform → Perform
Sep-13-24 Downgrade
JP Morgan
Neutral → Underweight
$88 → $70
Sep-13-24 Downgrade
Jefferies
Buy → Hold
$120 → $65
Aug-28-24 Upgrade
HSBC Securities
Reduce → Hold
$82
Aug-07-24 Upgrade
Deutsche Bank
Sell → Hold
$85 → $80
Aug-05-24 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$125 → $90
Show Previous Ratings
Aug-21-26 08:19PM
08:00PM
(The Wall Street Journal)
06:14PM
05:59PM
05:19PM
04:13PM
Loading…
04:13PM
02:57PM
02:54PM
02:26PM
02:15PM
10:54AM
(Investor's Business Daily)
10:37AM
(Investor's Business Daily)
08:08AM
07:18AM
07:09AM
07:03AM
Loading…
07:03AM
06:00AM
04:20AM
04:07AM
Aug-20-26 10:46PM
07:55PM
04:20PM
04:18PM
04:03PM
03:43PM
03:20PM
03:01PM
02:37PM
02:36PM
02:21PM
02:16PM
Loading…
02:16PM
01:26PM
01:22PM
12:51PM
12:44PM
12:43PM
(Investor's Business Daily)
11:51AM
(The Wall Street Journal)
11:42AM
11:30AM
10:58AM
10:15AM
10:06AM
10:02AM
09:46AM
(The Wall Street Journal)
08:10AM
07:31AM
06:57AM
06:44AM
06:36AM
06:01AM
05:59AM
05:32AM
05:10AM
04:58AM
03:32AM
12:05AM
Aug-19-26 10:43PM
10:20PM
08:34PM
07:55PM
07:33PM
06:37PM
06:21PM
05:34PM
05:23PM
04:35PM
04:35PM
04:25PM
04:01PM
03:38PM
03:38PM
02:54PM
02:29PM
(The Wall Street Journal)
02:07PM
02:06PM
01:52PM
01:49PM
01:37PM
01:30PM
01:23PM
01:19PM
12:54PM
12:53PM
12:13PM
12:00PM
(The Wall Street Journal)
11:51AM
11:48AM
11:41AM
11:16AM
11:15AM
10:46AM
10:43AM
10:38AM
10:34AM
10:16AM
10:14AM
10:09AM
09:39AM
09:38AM
09:29AM
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
CEO & Director Mr. Stephane Bancel M.B.A.
President Dr. Stephen Hoge M.D.
Chief Financial Officer Mr. James M. Mock
Chief Legal Officer & Corporate Secretary Ms. Shannon Thyme Klinger J.D.
Chief Technical Operations & Quality Officer Dr. Jerh Collins Ph.D.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Bancel Stephane Chief Executive Officer Aug 05 '26 Option Exercise 19.15 499,246 9,560,561 6,687,037 Aug 07 04:11 PM Bancel Stephane Chief Executive Officer Aug 06 '26 Option Exercise 19.15 252,469 4,834,781 6,440,260 Aug 07 04:11 PM Bancel Stephane Chief Executive Officer Aug 05 '26 Sale 57.52 499,246 28,715,011 6,187,791 Aug 07 04:11 PM Bancel Stephane Officer Aug 05 '26 Proposed Sale 58.00 499,246 28,956,268 Aug 05 01:02 PM Hoge Stephen President Jul 15 '26 Option Exercise 19.15 53,336 1,021,384 1,537,184 Jul 16 04:45 PM Hoge Stephen President Jul 15 '26 Sale 67.60 53,336 3,605,514 1,483,848 Jul 16 04:45 PM Hoge Stephen Officer Jul 15 '26 Proposed Sale 67.60 53,336 3,605,514 Jul 15 10:22 AM SAGAN PAUL Former Director Jun 18 '26 Proposed Sale 64.57 25,770 1,663,875 Jun 18 03:26 PM Hoge Stephen President Jun 15 '26 Option Exercise 19.15 53,336 1,021,384 1,537,184 Jun 17 04:10 PM Hoge Stephen President Jun 15 '26 Sale 51.37 53,336 2,739,870 1,483,848 Jun 17 04:10 PM Hoge Stephen Officer Jun 15 '26 Proposed Sale 51.37 53,336 2,739,870 Jun 15 11:43 AM Klinger Shannon Thyme Chief Legal Officer Jun 04 '26 Option Exercise 30.96 3,471 107,462 70,939 Jun 08 04:34 PM Klinger Shannon Thyme Chief Legal Officer Jun 04 '26 Sale 50.00 3,471 173,550 67,468 Jun 08 04:34 PM Klinger Shannon Thyme Officer Jun 04 '26 Proposed Sale 50.00 3,471 173,550 Jun 04 01:26 PM AFEYAN NOUBAR Director May 21 '26 Option Exercise 19.15 9,263 177,386 13,187 May 22 07:00 PM AFEYAN NOUBAR Director May 21 '26 Sale 46.84 9,263 433,879 3,924 May 22 07:00 PM Flagship Pioneering, LLC Affiliate May 21 '26 Proposed Sale 46.84 9,263 433,880 May 21 03:06 PM Hoge Stephen President May 15 '26 Option Exercise 19.15 53,336 1,021,384 1,531,333 May 18 04:57 PM Hoge Stephen President May 15 '26 Sale 48.40 53,336 2,581,462 1,477,997 May 18 04:57 PM Hoge Stephen Officer May 15 '26 Proposed Sale 48.40 53,336 2,581,462 May 15 09:47 AM SAGAN PAUL Former Director May 08 '26 Proposed Sale 54.48 36,759 2,002,787 May 08 11:24 AM Hussain Abbas Director May 01 '26 Sale 46.63 5,682 264,952 12,066 May 04 05:25 PM Hussain Abbas Director May 01 '26 Proposed Sale 46.63 5,682 264,952 May 01 11:44 AM Klinger Shannon Thyme Chief Legal Officer Mar 02 '26 Option Exercise 30.96 13,885 429,880 73,574 Mar 03 04:10 PM Klinger Shannon Thyme Chief Legal Officer Mar 02 '26 Sale 52.29 13,885 726,047 59,689 Mar 03 04:10 PM Klinger Shannon Thyme Officer Mar 02 '26 Proposed Sale 52.29 13,885 726,047 Mar 02 09:56 AM Hoge Stephen President Feb 23 '26 Option Exercise 19.15 160,009 3,064,172 1,617,436 Feb 25 04:49 PM Hoge Stephen President Feb 23 '26 Sale 48.84 160,009 7,814,840 1,457,427 Feb 25 04:49 PM Hoge Stephen Officer Feb 23 '26 Proposed Sale 48.84 160,009 7,814,840 Feb 23 10:26 AM AFEYAN NOUBAR Director Dec 11 '25 Option Exercise 10.90 23,853 259,998 27,777 Dec 15 09:00 AM AFEYAN NOUBAR Director Dec 11 '25 Sale 29.48 23,853 703,306 3,924 Dec 15 09:00 AM Bancel Stephane Chief Executive Officer Dec 11 '25 Option Exercise 10.90 688,073 7,499,996 6,181,970 Dec 15 08:59 AM Flagship Pioneering Inc. Affiliate Dec 11 '25 Proposed Sale 29.49 23,853 703,306 Dec 11 04:30 PM Hussain Abbas Director Dec 09 '25 Sale 27.60 504 13,910 1,515 Dec 11 04:16 PM Hussain Abbas Director Dec 09 '25 Proposed Sale 27.60 504 13,910 Dec 09 10:26 AM